Riverwater Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.26M Sell
59,896
-2,174
-4% -$106K 0.97% 30
2026
Q1
$2.66M Buy
62,070
+1,442
+2% +$62K 0.89% 33
2025
Q4
$2.66M Buy
60,628
+10,542
+21% +$436K 1.03% 22
2025
Q3
$2.07M Buy
50,086
+9,347
+23% +$376K 0.86% 33
2025
Q2
$1.8M Sell
40,739
-15,667
-28% -$626K 0.85% 32
2025
Q1
$2.08M Sell
56,406
-1,038
-2% -$37K 1.07% 23
2024
Q4
$1.91M Buy
+57,444
New +$1.86M 0.93% 27

Other funds holding EXEL

Riverwater Partners's EXEL Position: Q2 2026 in Review

Riverwater Partners reduced its Exelixis (EXEL) stake by 3.5% in Q2 2026, selling an estimated $106K and leaving 59,896 shares worth $3.26M. The position accounts for 0.97% of the portfolio, ranked #30.

Riverwater Partners first reported a position in EXEL in Q4 2024 and has held it in 7 quarters since. 759 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Riverwater Partners held 59,896 shares of Exelixis worth $3.26M as of Q2 2026.
  • Riverwater Partners sold 2,174 Exelixis shares in Q2 2026, an estimated $106K.
  • Exelixis made up 0.97% of Riverwater Partners's portfolio in Q2 2026, its #30 holding.
  • Riverwater Partners first reported a position in Exelixis in Q4 2024 and has held it in 7 quarters since.
  • 759 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.